Abstract:Cardiac fibrosis is an important pathological basis of various cardiovascular diseases. The roles of STAT6 signal in allergy, immune regulation, tumorigenesis, and renal fibrosis have been documented. However, the function and mechanism of STAT6 signal in sympathetic overactivation-induced cardiac fibrosis have not been fully elucidated. This study explores the novel role of STAT6 signal in isoproterenol (ISO)-induced cardiac fibrosis through the regulation of inflammatory response and the differentiation of macrophages from immature myeloid cells. The expression levels of STAT6, beta 1-adrenergic receptor (beta 1-AR), and inflammatory factors [interleukin alpha (IL-1 alpha), IL-6, IL-18, and transforming growth factor beta (TGF-beta)] in CD11b(+) myeloid cells were analyzed with a microarray study. The levels of IL-6 and TGF-beta 1 in the CD11b(+) myeloid cells-derived macrophages were detected with reverse transcriptase-polymerase chain reaction (RT-PCR). STAT6-knockout (KO) and WT mice were used to establish a murine cardiac fibrosis model by ISO injection. Cardiac fibroblasts were isolated from the hearts of newborn STAT6-KO and WT mice, and STAT6 expression was measured by Western blotting and RT-PCR after ISO stimulation, while alpha-smooth muscle actin (alpha-SMA) expression was detected by immunofluorescence and immunohistochemistry staining. Cardiac function and pathological characteristics were examined by echocardiography and immunohistochemistry staining, respectively. Immunohistochemistry staining with anti-CD11b was performed to detect the infiltration of CD11b(+) myeloid cells in heart tissue. Flow cytometry analysis was used to measure the percentages of CD11b(+) myeloid cells and CD11b(+)Ly6C(+) macrophages in the peripheral blood. The results showed that STAT6 was highly expressed in CD11b(+) myeloid cells located in injured hearts, and STAT6 expression in cardiac fibroblasts was down-regulated after ISO treatment. STAT6 deficiency further aggravated ISO-induced increased expression of alpha-SMA in cardiac fibroblasts, myocardial fibrosis, and cardiac dysfunction. The activation of ISO/beta 1-AR signal aggravated cardiac inflammatory infiltration, promoted CD11b(+) myeloid cell mobilization, and enhanced CD11b(+)Ly6C(+/low) macrophage differentiation, which was further exacerbated by STAT6 deficiency. Furthermore, beta 1-AR mRNA expression significantly increased in splenic CD11b(+) myeloid cells compared to their bone marrow-derived controls, and STAT6 deficiency promoted beta 1-AR expression in an MI-induced sensitive cardiac fibrosis mouse model. The spleen-derived CD11b(+) myeloid cells of STAT6-KO mice produced more IL-1 alpha, IL-18, and TGF-beta than their WT counterparts. Taken together, these results suggest that STAT6 signal plays a critical role in ISO-induced beta 1-AR overactivation and systemic inflammatory cascades, contributing to cardiac fibrogenesis. STAT6 should be a promising cardioprotective target against myocardial fibrosis and heart failure after beta 1-AR overactivation-induced myocardial injury.

Inhibiting STAT5 significantly attenuated Ang II-induced cardiac dysfunction and inflammation

Inhibition of Histone Demethylase JMJD1C Attenuates Cardiac Hypertrophy and Fibrosis Induced by Angiotensin II

Angiotensin II Causes Biphasic STAT3 Activation Through TLR4 to Initiate Cardiac Remodeling

Interleukin-5 alleviates cardiac remodelling via the STAT3 pathway in angiotensin II-infused mice

Hint1 (Histidine Triad Nucleotide-Binding Protein 1) Attenuates Cardiac Hypertrophy Via Suppressing Hoxa5 (Homeobox A5) Expression

Heat-shock transcription factor 1 is critically involved in the ischaemia-induced cardiac hypertrophy via JAK2/STAT3 pathway.

The novel peptide athycaltide-1 attenuates Ang II-induced pathological myocardial hypertrophy by reducing ROS and inhibiting the activation of CaMKII and ERK1/2

High density lipoprotein downregulates angiotensin II type 1 receptor and inhibits angiotensin II-induced cardiac hypertrophy.

Disruption of STAT6 Signal Promotes Cardiac Fibrosis Through the Mobilization and Transformation of CD11b<SUP>+</SUP> Immature Myeloid Cells

1,12-cyclic apelin-12 ameliorates Ang II and Apelin-13-induced cardiac hypertrophy by reducing mitochondrial oxidative damage

TNIP3 protects against pathological cardiac hypertrophy by stabilizing STAT1

Mechanism of cardiac hypertrophy: Effect of mitogen activated protein kinase inhibitor on expression of platelet-derived growth factor receptor induced by angiotensin II in cardiac myocytes

Transactivated EGFR Mediates Α₁-Ar-induced STAT3 Activation and Cardiac Hypertrophy.

Inhibitory Molecules in Signal Transduction Pathways of Cardiac Hypertrophy

Angiotensin II prompts heart cell apoptosis via AT1 receptor-augmented phosphatase and tensin homolog and miR-320-3p functions to enhance suppression of the IGF1R-PI3K-AKT survival pathway

Ang II Promotes Cardiac Autophagy and Hypertrophy via Orai1/STIM1

JAK/STAT3 signaling pathway is involved in α1-AR-mediated cardiac hypertrophy

GW24-e3170 Angiotensin-(1-7) Downregulates Angiotensin II Type 1 Receptor and Inhibites Mechanical Stress-Induced Cardiomyocyte Autophagy

Simvastatin inhibits angiotensin II-induced cardiac cell hypertrophy: role of Homer 1a.

Cardiomyocyte-enriched USP20 Ameliorates Pathological Cardiac Hypertrophy by Targeting STAT3-CARM1 Axis

Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy